Amorfix Announces Financial Results For Nine-month Period Ended December …
Stockhouse TORONTO, March 31, 2014 /CNW/ – Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the three and nine month period … |